Efficacy and effectiveness of COVID-19 vaccines: progress and prospect
One Health Bulletin
; 1(17):17-23, 2021.
Article
in English
| CAB Abstracts | ID: covidwho-2268908
ABSTRACT
To prevent and control COVID-19, COVID-19 vaccines are being developed, tested, and approved at an unprecedented rate. As of September 24, 2021, 22 types of COVID-19 vaccines have been approved for conditional marketing or emergency use by at least one country worldwide. Vaccine efficacy/effectiveness is a crucial concern for vaccination. This article provides an overview of efficacy of phase III clinical trials, vaccination, effectiveness of real-world studies as well as challenges of COVID-19 vaccine.
Host Resistance and Immunity [HH600], Prion; Viral; Bacterial and Fungal Pathogens of Humans [VV210], viral diseases, vaccines, vaccination, reviews, public health, immunization, human diseases, health protection, efficacy, disease prevention, coronavirus disease 2019, clinical trials, immune sensitization, Severe acute respiratory syndrome coronavirus 2, man, Severe acute respiratory syndrome-related coronavirus, Betacoronavirus, Coronavirinae, Coronaviridae, Nidovirales, positive-sense ssRNA Viruses, ssRNA Viruses, RNA Viruses, viruses, Homo, Hominidae, primates, mammals, vertebrates, Chordata, animals, eukaryotes, viral infections, SARS-CoV-2
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Experimental Studies
Topics:
Vaccines
Language:
English
Journal:
One Health Bulletin
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS